ArticleCancers2023

Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance.

Tapan K Maity et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.